Current Clinical Trials on Vitiligo / Switra in Ayurveda / Venpadai in Siddha

Current Clinical Trials on Vitiligo (Switra in Ayurveda, Venpadai in Siddha)

1. HI-Light Pilot Trial for Vitiligo: Hand Held NB-UVB for Early or Focal Vitiligo at Home
2. Online Health Survey of Patients With Vitiligo Vulgaris/ Online Survey of Pediatric Patients With Vitiligo
3. Vitiligo Skin Transplantation
4. Ginkgo Biloba for the Treatment of Vitiligo Vulgaris in Adolescents
5. Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Analysis)
6. Effect of Fluticasone Proprionate 0.05% on Narrow Band UV-B in Active Vitiligo
7. Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo (NSV)
8. Clinical Trial of Simvastatin to Treat Generalized Vitiligo
9. Botulinum Toxin Treatment for Localized Vitiligo
10. Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo
11. Punchgrafting Techniques for Vitiligo
12. Efficacy and Safety of ACH24 in the Treatment of Vitiligo
13. Treatment of Vitiligo With Low-energy Visible Light Laser
14. Narrowband UVB Treatment in Patients With Vitiligo
15. Topical Bimatoprost Solution 0.03%in Stable Vitiligo
16. Study of Applications of Autologous Epidermal Cells in Liquid Phase in the Treatment of Vitiligo
17. Epidermal Cell Transplantation in Vitiligo Skin With and Without Narrow-band Ultraviolet B (UVB) Treatment
18. Comparison of Efficacy and Safety of 0.1% Tacrolimus and 0.1% Mometasone Furoate for Adult Vitiligo
19. Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo
20. Questionnaire and Laboratory Data on Vitiligo Vulgaris
21. Emervel Deep Lidocaine vs. Juvederm® Ultra Plus in Treatment of Moderate to Severe Facial Wrinkles and Folds
22. Safety Study of Cosmetic Tissue Augmentation in People of Color
23. Trial for the Evaluation of the Effect of Systemic Low-dose Interleukin-2 (IL-2) on the Immunogenicity of a Vaccine Comprising Synthetic Melanoma Peptides Administered With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With High Risk Melanoma
24. Evaluation of Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea® vs Placebo
25. A Post-Market Study to Evaluate Adverse Event Incidence Rates in Patients With Skin of Color Undergoing Correction of Nasolabial Folds With Hylaform, Hylaform Plus and Captique.
26. Assessment of Atrophogenic Potential of Triple Combination Cream for Treatment of Melasma
27. Post Market Safety Study and Effectiveness With Evolence in Subjects With Skin Color Types IV-VI

Read more...

100 Current clinical trial details on rheumatoid arthritis

100 Current clinical trial details on rheumatoid arthritis
Click on title to view details.

1. A 3-year Study Following up Patients With Moderate to Severe Rheumatoid Arthritis Treated With Humira in Greece
2. A Dose Range Finding Study of JNJ-39758979 in Patients With Active Rheumatoid Arthritis Currently Treated With Methotrexate
3. A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
4. A Pilot Study of Potassium Supplementation for Adult Patients With Rheumatoid Arthritis
5. A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid Arthritis
6. A Study Comparing CRx-102 Plus Disease-Modifying Anti-Rheumatic Drug (DMARD) Therapy to Placebo Plus DMARD Therapy in Rheumatoid Arthritis
7. A Study Evaluating the Safety and Efficacy of Cura-100 in Subjects With Rheumatoid Arthritis and Osteoarthritis
8. A Study Exploring the Safety, Tolerability and Efficacy of a 4 Week Course of INCB018424 in Subjects With Active Rheumatoid Arthritis
9. A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis
10. A Study Of PF-04171327 In The Treatment Of The Signs And Symptoms Of Rheumatoid Arthritis
11. A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Juvenile Rheumatoid Arthritis
12. A Study of the Safety and Effectiveness of Lyophilized Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis
13. A Study of the Safety of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis
14. A Study on the Prevalence of the Anti-MCV Anti-body in an Irish Rheumatoid Arthritis (RA) Population and the Impact of Biomarker Status on the Management of Irish Patients With Early RA
15. A Study to Evaluate the RNA Signature of Rheumatoid Arthritis From Synovium and Whole Blood
16. A Trial to Evaluate the Safety and Tolerability of MT203 in Patients With Mild to Moderate Rheumatoid Arthritis
17. Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis
18. Assessment of Body Image in Patients With Rheumatoid Arthritis
19. Assessment of Pain Management in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients Who Are About to be Treated With Adalimumab
20. Atherosclerosis in Rheumatoid Arthritis
21. Clinically Important Changes in Rheumatoid Arthritis
22. Cognitive Behavioral Therapy Treatments for Adults With Rheumatoid Arthritis (The SARA Study)
23. Coping Skills Training for Early Rheumatoid Arthritis
24. Cost Utility Analyses of Adalimumab Treatment in Patients With Rheumatoid Arthritis (RA)
25. Diagnostic Value of Oral Prednisolone Test for Rheumatoid Arthritis
26. Effects Of CP-690,550 (Tasocitinib) On Cholesterol Metabolism In Patients With Active Rheumatoid Arthritis
27. Effects of Tranilast on Pharmacokinetics of Methotrexate (MTX) in Patients With Rheumatoid Arthritis (RA)
28.  Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis Treated Concomitantly With Methotrexate.
29. Efficacy and Safety of Adalimumab in Patients With Rheumatoid Arthritis in Routine Clinical Practice
30. Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drug (DMARD)-Naïve Adults With Early Active Rheumatoid Arthritis
31. Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drug (DMARD)-Naïve Adults With Early Active Rheumatoid Arthritis
32. Efficacy of Oncoxin Plus Viusid in the Treatment of Rheumatoid Arthritis
33. Evaluation of EULAR-RAID Score in Rheumatoid Arthritis Patients
34. Evaluation of the Role of Adalimumab on Extraarticular Manifestation - Bone Metabolism and Bone Mineral Density in Patients With Active Rheumatoid Arthritis
35. Exploratory Trial to Evaluate Premature Endothelial Dysfunction in Early Rheumatoid Arthritis(RA)Compared to Patients With Established RA, and Normal Subjects
36. Genetic and Immune Studies of Rheumatoid Arthritis and Related Conditions
37. Genetics of Rheumatoid Arthritis
38. Health Outcomes in Rheumatoid Arthritis
39. Humira in Rheumatoid Arthritis - Do Bone Erosions Heal?
40. Hydroxychloroquine to Improve Insulin Sensitivity in Rheumatoid Arthritis
41. Identification of Genes Associated With Lung Disease in Patients With Rheumatoid Arthritis
42. Inflammation and Insulin Resistance in Rheumatoid Arthritis
43. Infliximab for the Treatment of Early Rheumatoid Arthritis
44. Infliximab to Treat Children With Juvenile Rheumatoid Arthritis
45. Interest of a Standardized Monitoring of Rheumatoid Arthritis: The COMEDRA Trial
46. Iyengar Yoga for Young People With Rheumatoid Arthritis
47. Low Density Lipoprotein Cholesterol (CLDL) as a Cardiovascular Disease Risk Factor in Rheumatoid Arthritis
48. Lung Disease Associated With Rheumatoid Arthritis
49. Magnetic Resonance Image Verified Early Response to Certolizumab Pegol in Subjects With Active Rheumatoid Arthritis (RA)
50. Meditation-Based Stress Reduction in Rheumatoid Arthritis
51. Moderate Rheumatoid Arthritis (RA) With Enbrel
52. Monitoring Epstein-Barr Virus (EBV) Load in Rheumatoid Arthritis Patients Treated With New Immunosuppressive Drugs
53. Open Label Study to Assess the Predictability of Early Response to Certolizumab Pegol in Patients With Rheumatoid Arthritis
54. Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Switch to Infliximab After Incomplete Response to Etanercept
55. Orally Active, Small Molecule Inhibitor of MEK1 and MEK2 in Patients With Active Rheumatoid Arthritis
56. Patient Rheumatoid Arthritis Social Support Study
57. Phase II Study Evaluating the Safety and Efficacy of GSK315234 in Patients With Rheumatoid Arthritis
58. Physical Activity Behavior of Rheumatoid Arthritis Patients and Healthy Controls
59. Positron Emission Tomography and Magnetic Resonance Imaging to Evaluate Synovial Blood Flow in Rheumatoid Arthritis Patients
60. PPAR-gamma Agonists, Rheumatoid Arthritis and Cardiovascular Disease
61. Relaxation Response Training for the Treatment of Rheumatoid Arthritis
62. Rheumatoid Arthritis (DMARD) Intervention and UtilizationStudy
63. Rheumatoid Arthritis Disease Activity Monitor
64. Rheumatoid Arthritis DMARD Intervention and UtilizationStudy
65. Rheumatoid Arthritis: Comparison of Active Therapies in Patients With Active Disease Despite Methotrexate Therapy
66. Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA)
67. Rosuvastatin in Rheumatoid Arthritis (RORA)
68. Safety and Effect on Quality of Life/Work Productivity of Humira in Patients With Rheumatoid Arthritis
69.  Safety and Effectiveness of Adalimumab in Patients Diagnosed With Rheumatoid Arthritis
70.  Safety and Effectiveness of Infliximab in Slovakia When Used for Rheumatoid Arthritis (Study P04741)(COMPLETED)
71. Safety and Efficacy of ACZ885 in Adult Patients With Established Rheumatoid Arthritis
72. Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Rheumatoid Arthritis
73. Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid Arthritis
74. Safety Study of SCIO-469 to Treat Patients With Active Rheumatoid Arthritis Receiving Methotrexate
75. Serum Concentration of Adalimumab as a Predictive Factor of Clinical Outcomes in Rheumatoid Arthritis (AFORA)
76. Special Investigation in Patients With Rheumatoid Arthritis (Working Productivity Activity Impairment)
77. Specimen Collection for Individuals With Lung Disease Associated With Rheumatoid Arthritis
78. Standard Disease Activity Parameters and Step Activity in Patients With Rheumatoid Arthritis Receiving Etanercept
79. Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid Arthritis
80. Study Comparing Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Active Rheumatoid Arthritis Despite Current Methotrexate Therapy
81. Study Evaluating Enbrel In Adults With Active Rheumatoid Arthritis In Luxemburg
82. Study Evaluating Enbrel in Patients With Rheumatoid Arthritis
83. Study Evaluating Single Doses Of SBI-087 in Subjects With Rheumatoid Arthritis
84. Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
85. Study of Enbrel in Rheumatoid Arthritis (RA) Subjects With Comorbid Disorders
86. Study of Human Leukocyte Antigen (HLA) Polymorphisms in Patients With Rheumatoid Arthritis
87. Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis
88. Targeting Synovitis in Early Rheumatoid Arthritis
89. The Controlled Trial of Apremilast for Rheumatoid Arthritis Treatment (CARAT)
90. The Relation Between Dedicated Extremity MRI Synovitis and Structural Deterioration Radiographic in Patients With Rheumatoid Arthritis in Clinical Remission. Preliminary Study
91. The Role of Cytokines on Growth Hormone Suppression in Premenopausal Women With Rheumatoid Arthritis and the Effect of Treatment With Etanercept
92. The Use of Anti-CD4 Monoclonal Antibody (mAb)-Fragment for the Imaging of Chronic Inflammation in Patients With Active Rheumatoid Arthritis
93. Time to DMARD (Disease-Modifying Anti-Rheumatic Drug) Treatment and Actual Work Limitation of Patients With Rheumatoid Arthritis in Turkey
94. TIV and High Dose TIV in Subjects With Rheumatoid Arthritis
95. Treating Rheumatoid Arthritis With Tripterygium Wilfordi Hook F or Sulfasalazine
96. Treatment of Hypovitaminosis D in Rheumatoid Arthritis
97. Treatment of Vitamin D Deficiency in Patients With Rheumatoid Arthritis
98. Ultrasonography as a Biomarker in Early Rheumatoid Arthritis
99. Ultrasound Scores as Indication of Response to Subcutaneous Abatacept in Subjects With Rheumatoid Arthritis
100. Zostavax in Rheumatoid Arthritis

Read more...

Psoriasis Clinical Trials

Current / Recent Psoriasis Clinical Trials.  Click title to view trial details.

1. Efficacy Study of the Combination Mometasone + Salicylic Acid in Patients With Psoriasis
2.  Effectiveness of Association Mometasone Furoate 0.1% and Salicylic Acid 5% Compared With Mometasone Furoate
3.  Effects of Etanercept on Nail Psoriasis and Plaque Psoriasis
4. Serum Lipid Levels and Other Biomarkers of Cardiovascular Disease in Patients With Psoriasis
5. A Post Marketing Observational Study (PMOS) of the Quality of Life in Adalimumab Treated Psoriasis Patients Failing Other Biological Disease Modifying Anti-rheumatic Drugs (BDMARDs) Over 1 Year
6. Prevalence of Sleep Disturbances in Psoriasis
7. Effectiveness of Adalimumab (HUMIRA®) in the Treatment of Scalp and Nail Affection in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice
8. Effectiveness of Adalimumab in Moderate to Severe Plaque Psoriasis Patients With Distinct Co-morbidities
9. Peds Metabolic Syndrome in Psoriasis
10. A Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque Psoriasis
11. A Case Control Study Evaluating the Prevalence of Non-Alcoholic Fatty Liver Disease Among Patients With Psoriasis
12. The Effect of Weight Loss on Psoriasis Area Severity Index in Adult Psoriasis Patients
13. Study Evaluating The Prevalence Of Undiagnosed Psoriatic Arthritis In Patients With Plaque Psoriasis
14. Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis
15. Psoriasis Longitudinal Assessment and Registry (PSOLAR)
16. Premature Coronary Artery Disease (CAD) in Severe Psoriasis
17. CYA Versus MMF for Treatment of Moderate-Severe Psoriasis.
18. A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis
19. Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis
20. Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
21. A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriasis
22. Documentation of Humira in Psoriasis Patients in Routine Clinical Practice
23. A Study to Evaluate the Efficacy and Tolerability of Topical Therapies for the Condition of Plaque-Type Psoriasis
24. Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis
25. Utilization of Narrow Band Ultraviolet B (UVB) Light Therapy and Etanercept for the Treatment of Psoriasis
26. Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis
27. Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis
28. Open-Label,Single-Arm Pilot Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Preliminary Efficacy of CC1004 in Subjects With Severe Plaque Type Psoriasis
29. Efficacy and Safety of Calcipotriene/Betamethasone Gel/Ointment in Psoriasis
30. A Study for Adults With Plaque Psoriasis
31. A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)
32. A Study of Efalizumab in Patients With Moderate to Severe Chronic Psoriasis Who Have Failed, Have a Contraindication to, or Are Intolerant of Other Systemic Therapies
33. A Phase IV Clinical Trial to Study the Safety, Tolerability and Efficacy of Tinefcon in Patients With Plaque Psoriasis
34. Double-Blind, Randomised, Placebo-Controlled Trial Investigating BIRT 2584 XX in Patients With Moderate/Severe Psoriasis
35. Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type Psoriasis
36. Adalimumab in Adult Japanese Subjects With Psoriasis
37. Study Evaluating the Efficacy and Safety of Triptergium Wilfordii and Acitretin in Psoriasis Vulgaris - CHINA201002016-2
38. Study Evaluating Etanercept in the Treatment of Subjects With Psoriasis
39. A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Moderate to Severe Plaque Psoriasis With Involvement of the Scalp
40. Study Evaluating Single Dose Of ILV-095 In Psoriasis Subjects
41. Cross-sectional Evaluation of Biological Markers of Cardiovascular Disease in Children and Adolescents With Psoriasis
42. A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
43. Double-Blind, Randomized, Placebo-Controlled Comparison of CC10004 in Subjects With Moderate to Severe Plaque Type Psoriasis
44. A Study of the Safety and Effectiveness of Infliximab in Patients With Plaque-type Psoriasis
45. Sensitivity and Specificity of QuantiFeron -TB Gold Test (QFT-G)in Patients With Psoriasis
46. Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type Psoriasis
47. Randomized Study of PH-10 for Psoriasis
48. A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
49. AIN457 Regimen Finding Study in Patients With Moderate to Severe Psoriasis
50. Efficacy and Safety of Subcutaneous Secukinumab for Moderate to Severe Chronic Plaque-type Psoriasis for up to 1 Year
51. A Study of Tetrathiomolybdate in the Treatment of Psoriasis Vulgaris
52. A Dose Ranging Study of AIN457 in Patients With Moderate to Severe Chronic Plaque-type Psoriasis
53. A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis.
54. A Double Blind Study in Pediatric Subjects With Chronic Plaque Psoriasis, Studying Adalimumab vs. Methotrexate
55. Raptiva in Palm and Sole Psoriasis
56. Efficacy and Safety of Cyclosporine A Microemulsion in Maintenance Patients With Chronic Plaque Psoriasis
57. Nurse Education in Subjects With Psoriasis Undergoing Treatment With Adalimumab
58. Assess the Efficacy and Safety of Alefacept With Narrow Band Ultraviolet B Phototherapy (nbUVB) vs. Alefacept Alone in Chronic Plaque Psoriasis Subjects
59. A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
60. Infliximab in High Need Versus Low Need Psoriasis Patients: The IHELP Study (Study P04320)

Read more...